Daily News Podcast

Heart failure and sacubiril/valsartan


 

A practice-changing study on in-hospital initiation of sacubitril-valartan finds that the practice is safe and effective in acute decompensated heart failure. Also today, concussion or TBI early in life is linked to suicide risk later, revised cholesterol guidelines veer toward personalized risk assessment, and sibling violence is the most common form of family violence.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Is it time to revise ASCVD cardiovascular risk threshold?
MDedge Rheumatology
Samuel Shem: House of God
MDedge Rheumatology
FDA approves sufentanil
MDedge Rheumatology
CMS pulls back on E/M payment proposal
MDedge Rheumatology
Most nonemergent diagnoses can’t be predicted
MDedge Rheumatology
Hypertension and CVD risk for young adults
MDedge Rheumatology
Biomarkers and concussions
MDedge Rheumatology
Some statins worse than others for musculoskeletal adverse event onset time
MDedge Rheumatology
Samuel Shem: Part II
MDedge Rheumatology
Trump rule and ACA contraception
MDedge Rheumatology